PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
V3AB.L vs. AZN.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

V3AB.L vs. AZN.L

Last updated Jun 5, 2026

V3AB.L (Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating) is Global Equities fund tracking the MSCI ACWI NR USD, while AZN.L (AstraZeneca plc) is a stock. Over the past 5 years, V3AB.L returned 11.91%/yr vs 13.33%/yr for AZN.L. At a 0.24 correlation, their price movements are largely independent.

Performance

V3AB.L vs. AZN.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating (V3AB.L) and AstraZeneca plc (AZN.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

V3AB.L is traded in GBP, while AZN.L is traded in GBp. To make them comparable, the AZN.L values have been converted to GBP using the latest available exchange rates.

Returns By Period

In the year-to-date period, V3AB.L achieves a 12.14% return, which is significantly higher than AZN.L's -0.69% return.

V3AB.L

1D
0.03%
1M
6.33%
YTD
12.14%
6M
12.90%
1Y
30.24%
3Y*
17.81%
5Y*
11.91%
10Y*
—

AZN.L

1D
2.60%
1M
1.68%
YTD
-0.69%
6M
1.34%
1Y
28.09%
3Y*
6.86%
5Y*
13.33%
10Y*
16.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

V3AB.L vs. AZN.L - Yearly Performance Comparison

2026 (YTD)20252024202320222021
V3AB.L
Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating		12.14%12.22%19.77%17.95%-11.67%17.38%
AZN.L
AstraZeneca plc		-0.69%34.59%0.92%-3.53%32.32%21.32%

Correlation

The correlation between V3AB.L and AZN.L is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Mar 26, 2021

0.24

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating

AstraZeneca plc

Often compared with V3AB.L:
V3AB.L vs. VWRP.LV3AB.L vs. VWRL.ASV3AB.L vs. V3AM.LV3AB.L vs. VUAG.LV3AB.L vs. SSAC.LV3AB.L vs. ESGG.LV3AB.L vs. VUSA.L
Often compared with AZN.L:
AZN.L vs. GSKAZN.L vs. GSK.LAZN.L vs. SPYAZN.L vs. PFEAZN.L vs. PFIZER.NSAZN.L vs. NEONAZN.L vs. TEVA

Return for Risk

V3AB.L vs. AZN.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
V3AB.L
V3AB.L Risk / Return Rank: 8080
Overall Rank
V3AB.L Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
V3AB.L Sortino Ratio Rank: 8080
Sortino Ratio Rank
V3AB.L Omega Ratio Rank: 8383
Omega Ratio Rank
V3AB.L Calmar Ratio Rank: 7676
Calmar Ratio Rank
V3AB.L Martin Ratio Rank: 8080
Martin Ratio Rank
AZN.L
AZN.L Risk / Return Rank: 7474
Overall Rank
AZN.L Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
AZN.L Sortino Ratio Rank: 7575
Sortino Ratio Rank
AZN.L Omega Ratio Rank: 7070
Omega Ratio Rank
AZN.L Calmar Ratio Rank: 7373
Calmar Ratio Rank
AZN.L Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

V3AB.L vs. AZN.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating (V3AB.L) and AstraZeneca plc (AZN.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

V3AB.LAZN.LDifference
Sharpe ratioReturn per unit of total volatility
2.58
1.14

+1.44

Sortino ratioReturn per unit of downside risk
3.56
1.98

+1.58

Omega ratioGain probability vs. loss probability

1.49

1.22

+0.27

Calmar ratioReturn relative to maximum drawdown

3.76

1.86

+1.90

Martin ratioReturn relative to average drawdown

15.42

4.85

+10.56

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

V3AB.L vs. AZN.L - Sharpe Ratio Comparison

The current V3AB.L Sharpe Ratio is 2.58, which is higher than the AZN.L Sharpe Ratio of 1.14. The chart below compares the historical Sharpe Ratios of V3AB.L and AZN.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

V3AB.LAZN.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.58

1.14

+1.44

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.87

0.56

+0.31

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

—

0.66

—

Sharpe Ratio (All Time)

Calculated using the full available price history

0.91

0.53

+0.39

Drawdowns

V3AB.L vs. AZN.L - Drawdown Comparison

The maximum V3AB.L drawdown since its inception was -19.00%, smaller than the maximum AZN.L drawdown of -49.99%. Use the drawdown chart below to compare losses from any high point for V3AB.L and AZN.L.

Loading charts...

Drawdown Indicators

V3AB.LAZN.LDifference

Max Drawdown

Largest peak-to-trough decline

-19.00%

-49.99%

+30.99%

Max Drawdown (1Y)

Largest decline over 1 year

-8.00%

-15.00%

+7.00%

Max Drawdown (3Y)

Largest decline over 3 years

-19.00%

-26.75%

+7.75%

Max Drawdown (5Y)

Largest decline over 5 years

-19.00%

-26.75%

+7.75%

Max Drawdown (10Y)

Largest decline over 10 years

—

-26.75%

—

Current Drawdown

Current decline from peak

-0.55%

-12.79%

+12.24%

Average Drawdown

Average peak-to-trough decline

-4.22%

-11.69%

+7.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.96%

5.77%

-3.81%

Volatility

V3AB.L vs. AZN.L - Volatility Comparison

The current volatility for Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating (V3AB.L) is 3.38%, while AstraZeneca plc (AZN.L) has a volatility of 6.10%. This indicates that V3AB.L experiences smaller price fluctuations and is considered to be less risky than AZN.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

V3AB.LAZN.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.38%

6.10%

-2.72%

Volatility (6M)

Calculated over the trailing 6-month period

8.82%

16.92%

-8.10%

Volatility (1Y)

Calculated over the trailing 1-year period

11.66%

24.50%

-12.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.72%

23.76%

-10.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.67%

24.32%

-10.65%

Dividends

V3AB.L vs. AZN.L - Dividend Comparison

V3AB.L has not paid dividends to shareholders, while AZN.L's dividend yield for the trailing twelve months is around 1.74%.

PositionTTM20252024202320222021202020192018201720162015
AZN.L
AstraZeneca plc		1.74%1.77%2.23%2.21%1.98%2.33%2.95%2.87%3.44%4.28%4.50%3.95%
V3AB.L
Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating		0.00%0.00%0.00%0.00%1.91%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

V3AB.L and AZN.L have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for V3AB.L and AZN.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer